Recent Posts
- Lawsuit Prompts U.S. State Department To Strengthen Protections Of HIV-Positive Contract Workers
- San Francisco Postpones Agency Cuts, Los Angeles AIDS Clearinghouse Closes
- Kennedy’s Contributions To HIV/AIDS, Gay Rights Policies Recalled
- Routine Circumcision Does Not Protect Against HIV For Men Who Have Sex With Men, CDC Study Finds
- NBA Legend Dikembe Mutombo, UNICEF Executive Director Ann M. Veneman And BD Commemorate Opening Of New Center To Improve HIV/AIDS Treatment In The DRC
Random Posts
- Video Game To Help Urban Teens Avoid HIV Infection Focus Of Nearly $4 Million Grant To Yale
- President Obama Releases Statement, Video Urging U.S. Residents To Get Tested For HIV
- UAB Awarded $11.5 Million To Explore Ways To Test Youth For HIV, Link Them To Care
- Ugandan Medical Male Circumcision Program Launched To Prevent HIV Transmission
- Financial Times To Launch Special Report On 'Combating AIDS' With Contribution To Global Business Coalition
- Thailand Aims To Halve New HIV Cases By 2011, Prime Minister Says
- Cell Phones Become Handheld Tools For Global Development
- Local Charity Calls For People Living With HIV Across The County To Give Their Views At A Major HIV Conference In Eastbourne
- Also In Global Health News: Funding Shortfall In Philippines; WHO-Approved ARV
- Outstanding Minority Physicians Receive Awards Dedicated To HIV Medicine
Prescription AIDS Drugs
Contact Us
The reason deadly infections like human immunodeficiency virus (HIV) and hepatitis C never go away is because these viruses disarm the body’s defense system. Researchers at the University of Alabama at Birmingham (UAB) have discovered that a key immunity protein must be present for this defense system to have a chance against chronic infection.
Research up to now has tried but failed to decipher the cross-talk between ‘killer T-cells’ and ‘helper T-cells’ in the fight against viruses. The new UAB study finds this cross-talk can only happen in the presence of interleukin-21, a powerful immune system protein. If interleukin-21 is missing for whatever reason, then the immune system’s anti-viral efforts fail, said Allan Zajac, Ph.D., an associate professor in UAB’s Department of Microbiology and lead author on the study.
The findings are published in the journal Science through its Science Express service.
“Adding interleukin-21 back in stimulates the immune response and controls the infection,” Zajac said. “We demonstrate that the loss of this protein prevents the control of the infection and diminishes the function of the killer T-cells, specifically CD8 T-cells.”
The study mice were treated for lymphocytic choriomeningitis, a viral infection of the membranes surrounding the brain and spinal cord. Measurements were taken for two types of T-cells, CD4 and CD8 T-cells, before and after the mice were treated with interleukin-21.
“Interleukin-21 served as the key messenger between the T-cells, whereas before we didn’t know exactly how the two types of cells communicated with each other,” Zajac said. The CD4 T-cells help the immune system do its job by boosting CD8 T-cells’ ability to fight and kill viruses.
Co-authors on the study include John Yi and Ming Du, Ph.D., both of UAB’s Department of Microbiology. Research funds came from the National Institutes of Health.
Source:
Troy Goodman
University of Alabama at Birmingham
Related posts:
- How Key Protein Keeps Chronic Infection In Check Why is the immune system able to fight off some...
- ‘Natural Killer’ Cells Keep Immune System In Balance Natural killer, or NK cells, are part of our...
- How HIV Cripples Immune Cells In order to be able to ward off disease pathogens,...
- Researchers Induce HIV-Neutralizing Antibodies That Recognize HIV-1 Envelope Protein, Lipids For the first time, researchers have experimentally induced antibodies that...
- The Mystery Of Why HIV Patients Are More Susceptible To TB Infection Solved By Harvard Scientists A team of Harvard scientists has taken an important first...
Related posts brought to you by Yet Another Related Posts Plugin.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.





